Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Androgen-Driven Fusion Genes and Chimeric Transcripts in Prostate Cancer
Mauro Scaravilli, Sonja Koivukoski, Leena Latonen
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy
Matin Chehelgerdi, Fereshteh Behdarvand Dehkordi, Mohammad Chehelgerdi, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 68
Circulating Tumor DNA Enables Sensitive Detection of Actionable Gene Fusions and Rearrangements Across Cancer Types
Pashtoon Murtaza Kasi, Jessica Lee, Lincoln W. Pasquina, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 4, pp. 836-848
Open Access | Times Cited: 23
Epithelial–Mesenchymal Transition Signaling and Prostate Cancer Stem Cells: Emerging Biomarkers and Opportunities for Precision Therapeutics
Luiz Paulo Chaves, Camila Morais Melo, Fabiano Pinto Saggioro, et al.
Genes (2021) Vol. 12, Iss. 12, pp. 1900-1900
Open Access | Times Cited: 48
The roles of proteases in prostate cancer
Hannu Koistinen, Ruusu‐Maaria Kovanen, Morley D. Hollenberg, et al.
IUBMB Life (2023) Vol. 75, Iss. 6, pp. 493-513
Open Access | Times Cited: 21
The Expression of Proto-Oncogene ETS-Related Gene (ERG) Plays a Central Role in the Oncogenic Mechanism Involved in the Development and Progression of Prostate Cancer
Ealia Khosh Kish, Muhammad Choudhry, Yaser Gamallat, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4772-4772
Open Access | Times Cited: 28
Investigation of Neural Microenvironment in Prostate Cancer in Context of Neural Density, Perineural Invasion, and Neuroendocrine Profile of Tumors
Dawid Sigorski, Jacek Gulczyński, Aleksandra Sejda, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 29
Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate Cancer
Eshwari Dathathri, Khrystany T. Isebia, Fikri Abali, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 22
Design, synthesis, and characterization of PROTACs targeting the androgen receptor in prostate and lung cancer models
Lukas Maria Gockel, Vladlena Pfeifer, Fabian Baltes, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 5
Open Access | Times Cited: 20
Isoform-level discovery, quantification and fusion analysis from single-cell and spatial long-read RNA-seq data with Bambu-Clump
Andre Sim, Min Hao Ling, Ying Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Fusion genes in cancers: Biogenesis, functions, and therapeutic implications
Haoneng Tang, Peng Qiu, Linda Oyang, et al.
Genes & Diseases (2025), pp. 101536-101536
Open Access
Exploring therapeutic applications of PTEN, TMPRSS2:ERG fusion, and tumour molecular subtypes in prostate cancer management
Fidelis Charles Bugoye, Rispah Torrorey-Sawe, Richard Biegon, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Transient Receptor Potential Channels in Prostate Cancer: Associations with ERG Fusions and Survival
Nirosha J. Murugan, Emma Genautis, Ioannis A. Voutsadakis
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3639-3639
Open Access
Chromoplexy: A Pathway to Genomic Complexity and Cancer Development
Franck Pellestor, Benjamin Ganne, Jean Baptiste Gaillard, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3826-3826
Open Access
Precision Targeting in Metastatic Prostate Cancer: Molecular Insights to Therapeutic Frontiers
Whi‐An Kwon, Jae Young Joung
Biomolecules (2025) Vol. 15, Iss. 5, pp. 625-625
Open Access
Nanomedicine-RNAi interface: Architypes in prostate cancer therapeutics
Saurabh Shah, Paras Famta, Dadi A. Srinivasarao, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 92, pp. 105349-105349
Closed Access | Times Cited: 3
HATCHet2: clone- and haplotype-specific copy number inference from bulk tumor sequencing data
Matthew A. Myers, Brian J. Arnold, Vineet Bansal, et al.
Genome biology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 3
CaV1.3 enhanced store operated calcium promotes resistance to androgen deprivation in prostate cancer
Debbie O’Reilly, Tim Downing, Sana Kouba, et al.
Cell Calcium (2022) Vol. 103, pp. 102554-102554
Open Access | Times Cited: 15
Novel Insights into the Role of the Antioxidants in Prostate Pathology
Vittoria Rago, Silvia Di Agostino
Antioxidants (2023) Vol. 12, Iss. 2, pp. 289-289
Open Access | Times Cited: 9
Breaking paradigms: Long non-coding RNAs forming gene fusions with potential implications in cancer
David Sánchez-Marín, Macrina B. Silva-Cázares, Fany Iris Porras-Reyes, et al.
Genes & Diseases (2023) Vol. 11, Iss. 3, pp. 101136-101136
Open Access | Times Cited: 6
Unravelling the Role of P300 and TMPRSS2 in Prostate Cancer: A Literature Review
Charitomeni Gioukaki, Alexandros Georgiou, Lydia Evangelia Gkaralea, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11299-11299
Open Access | Times Cited: 5
Complementary analysis of proteome‐wide proteomics reveals changes in RNA binding protein‐profiles during prostate cancer progression
Erika Aikio, Sonja Koivukoski, Elina Kallio, et al.
Cancer Reports (2023) Vol. 6, Iss. 10
Open Access | Times Cited: 5
Long non-coding RNAs and their potential impact on diagnosis, prognosis, and therapy in prostate cancer: racial, ethnic, and geographical considerations
Rebecca Morgan, Willian A. da Silveira, Ryan C. Kelly, et al.
Expert Review of Molecular Diagnostics (2021) Vol. 21, Iss. 12, pp. 1257-1271
Open Access | Times Cited: 12
Proteomic Landscape of Prostate Cancer: The View Provided by Quantitative Proteomics, Integrative Analyses, and Protein Interactomes
Nithin Sadeesh, Mauro Scaravilli, Leena Latonen
Cancers (2021) Vol. 13, Iss. 19, pp. 4829-4829
Open Access | Times Cited: 11
HATCHet2: clone- and haplotype-specific copy number inference from bulk tumor sequencing data
Matthew A. Myers, Brian J. Arnold, Vineet Bansal, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Fusion sequencing via terminator‐assisted synthesis (FTAS‐seq) identifies TMPRSS2 fusion partners in prostate cancer
Ugnė Drazdauskienė, Žana Kapustina, Justina Medžiūnė, et al.
Molecular Oncology (2023) Vol. 17, Iss. 6, pp. 993-1006
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top